Dr. Berndt’s research utilizes new analytic and bioinformatic methods in genetic and molecular epidemiology to elucidate the etiology of cancer and anthropometric traits and explores the impact of modifiable risk factors on cancer risk and mortality. She is the principal investigator for the Ghana Prostate Study, Prostate, Lung, Colorectal, and Ovarian (PLCO) Prostate Cancer Progression (PCP) Study, Expanded and Trans-ancestry Lymphoid Malignancies Genome-wide Association Studies, and Prostate Cancer GWAS of Uncommon Susceptibility Loci (PEGASUS). Dr. Berndt is the co-leader of the InterLymph Consortium Genetics Working Group and the Genetic Investigation of Anthropometric Traits (GIANT) Body Mass Index Working Group. She serves as the principal investigator representing the PLCO Cancer Screening Trial for the Genetic Investigation of Anthropometric Traits (GIANT), Prostate Cancer Association Group to Investigate Cancer Associated Alterations in the Genome (PRACTICAL), African American Prostate Cancer (AAPC), Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), and the Ghana Prostate Study for the Men of African Descent and Carcinoma of the Prostate (MADCaP) Consortium.